Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 9, 2006 - Issue 1-2
63
Views
16
CrossRef citations to date
0
Altmetric
Articles

Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa

, , , &
Pages 11-16 | Published online: 05 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Thomas Müller. (2008) Role of homocysteine in the treatment of Parkinson's disease. Expert Review of Neurotherapeutics 8:6, pages 957-967.
Read now

Articles from other publishers (15)

Siamak Tabibzadeh. (2022) Resolving Geroplasticity to the Balance of Rejuvenins and Geriatrins. Aging and disease 13:6, pages 1664.
Crossref
Rudra P. Ojha, Govind Prasad Dubey, V. N. Mishra, D. Jain, Sunil Dubey, Rajesh Dubey & Rajesh K. Kesharwani. 2022. Homocysteine Metabolism in Health and Disease. Homocysteine Metabolism in Health and Disease 205 228 .
Qiu-Qin Han, Yi Fu, Jia-Mei Le, Adam Pilot, Si Cheng, Pei-Qing Chen, Hailong Wu, Guo-Qing Wan & Xue-Feng Gu. (2021) Electroacupuncture may alleviate behavioral defects via modulation of gut microbiota in a mouse model of Parkinson’s disease. Acupuncture in Medicine 39:5, pages 501-511.
Crossref
Pushpendra D. Pratap, Syed Tasleem Raza, Sanju Pratap & Muneshwar Rajput. 2021. Nutritional Management and Metabolic Aspects of Hyperhomocysteinemia. Nutritional Management and Metabolic Aspects of Hyperhomocysteinemia 115 123 .
Elena Azzini, Stefania Ruggeri & Angela Polito. (2020) Homocysteine: Its Possible Emerging Role in At-Risk Population Groups. International Journal of Molecular Sciences 21:4, pages 1421.
Crossref
Caterina Tinelli, Antonella Di Pino, Elena Ficulle, Serena Marcelli & Marco Feligioni. (2019) Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies. Frontiers in Nutrition 6.
Crossref
Sabrina Anticoli, Francesca Romana Pezzella, Claudio Pozzessere, Luca Gallelli, Maria Cristina Bravi, Valeria Caso & Antonio Siniscalchi. (2015) Transient Ischemic Attack Fast-track and Long-Term Stroke Risk: Role of Diffusion-Weighted Magnetic Resonance Imaging. Journal of Stroke and Cerebrovascular Diseases 24:9, pages 2110-2116.
Crossref
Stefano de Franciscis, Giovambattista De Sarro, Paola Longo, Gianluca Buffone, Vincenzo Molinari, Domenico M Stillitano, Luca Gallelli & Raffaele Serra. (2015) Hyperhomocysteinaemia and chronic venous ulcers. International Wound Journal 12:1, pages 22-26.
Crossref
Hashem Haghdoost-Yazdi, Mohammad Sarookhani, Ayda Faraj, Negin Fraidouni, Tahereh Dargahi, Mohammad Hosein Yaghoubidoust & Hassan Azhdari-Zarmehri. (2014) Evaluation of the association between blood homocysteine concentration and the degree of behavioral symptoms in the 6-hydroxydopamine-induced Parkinsonism in rat. Pharmacology Biochemistry and Behavior 124, pages 297-304.
Crossref
Hashem Haghdoost-Yazdi, Negin Fraidouni, Ayda Faraji, Hassan Jahanihashemi & Mohammad Sarookhani. (2012) High intake of folic acid or complex of B vitamins provides anti-Parkinsonism effect: No role for serum level of homocysteine. Behavioural Brain Research 233:2, pages 375-381.
Crossref
Carla Manuela Crispim NASCIMENTO, Florindo STELLA, Célia Regina GARLIPP, Ruth Ferreira SANTOS, Sebastião GOBBI & Lilian Teresa Bucken GOBBI. (2011) Serum homocysteine and physical exercise in patients with Parkinson's disease. Psychogeriatrics 11:2, pages 105-112.
Crossref
Thomas Müller. 2010. Basic Aspects of Catechol-O-Methyltransferase and the Clinical Applications of its Inhibitors. Basic Aspects of Catechol-O-Methyltransferase and the Clinical Applications of its Inhibitors 49 71 .
Eliseu Felippe dos Santos, Estela Natacha Brandt Busanello, Anelise Miglioranza, Ângela Zanatta, Alethea Gatto Barchak, Carmen Regla Vargas, Jonas Saute, Charles Rosa, Maria Júlia Carrion, Daiane Camargo, André Dalbem, Jaderson Costa da Costa, Sandro René Pinto de Sousa Miguel, Carlos Roberto de Mello Rieder & Moacir Wajner. (2009) Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson´s disease. Metabolic Brain Disease 24:2, pages 257-269.
Crossref
Paolo Barone, David J. Burn, Teus van Laar, Chuanchieh Hsu, Werner Poewe & Roger M. Lane. (2008) Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients. Movement Disorders 23:11, pages 1532-1540.
Crossref
Birger Scholz, Marcus Svensson, Henrik Alm, Karl Sköld, Maria Fälth, Kim Kultima, Céline Guigoni, Evelyne Doudnikoff, Qin Li, Alan R. Crossman, Erwan Bezard & Per E. Andrén. (2008) Striatal Proteomic Analysis Suggests that First L-Dopa Dose Equates to Chronic Exposure. PLoS ONE 3:2, pages e1589.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.